European Association of Dermato-Oncology (EADO)

The EADO is a non-profit organization funded in 1999 to promote, coordinate and improve
clinical and laboratory research activities in the field of skin cancer including primary and secondary
prevention, early detection, clinical diagnosis and clinical and experimental research.
EADO has organized many successful meetings and the upcoming ones are visible on the
website (www.eado.org).
The EADO initiates for the eleventh time a course dedicated to fundamentals in skin cancer
targeted to specialists and residents in the final phase of their resident program. They will
benefit a comprehensive and updated course to improve their decision-making process for
the management of all types and stages of skin cancer, from diagnosis, primary treatment
and adjuvant treatment, to the management of locoregional disease and distant metastatic
disease.

Target Audience

This 2-day educational course targets doctors who are actively involved in the treatment
of skin cancer. Dermatologists or other specialists who have completed specialist training,
or residents in the final year of their training program, are likely to gain the most from this
course.

Educational Objectives

The principal aim of the course is to provide a comprehensive and detailed understanding
of the decision-making process for the management of all types and stages of skin cancer.
This will include diagnosis and primary treatment, management of locoregional disease and
distant metastatic disease, and adjuvant treatment. This is particularly relevant given the
rapid progress in our understanding of melanoma and non-melanoma skin cancer, and the
development of new treatments. In particular delegates will acquire the following knowledge:

• Strategies for diagnosis of melanoma, Merkel cell and non-melanoma skin cancer
• including dermoscopy and confocal laser microscopy.
• The indications, risks and benefits and strategies for mole screening.
• Diagnosis of skin cancer: how to break bad news.The indications and methods for genetic diagnosis and genetic counseling of skin cancer patients.
• The present AJCC staging systems and how to stage melanoma, Merkel cell and
• cutaneous squamous cell carcinoma, and other non-melanoma skin cancers.
• The value of imaging and biomarkers for the detection of metastases and disease staging.
• Adjuvant treatment of skin cancer: radiotherapy, immunotherapy, chemotherapy.
• New systemic treatments for stage IV melanoma: targeted agents and immunotherapeutics.
• New treatment options of advanced basal cell carcinoma.
• New systemic treatments for advanced Merkel cell and squamous cell carcinoma.
• The characteristics of mucosal and uveal melanomas and their treatment options.
• Options for topical treatment of epithelial skin cancers.The current classification of cutaneous lymphoma, staging and treatment options for different subtypes of cutaneous lymphoma.
• Clinical trials in skin cancer: an update.
• The indications and strategies for supportive treatments including best supportive care.

 Course Venue
Novotel Berlin am Tiergarten
Strasse des 17 Juni 106-108
10623 Berlin
Tel +49 30 600350
Fax +49 30 60035666

Email: h3649@accor.com